HCIA Resume Book 2019-2020

HEALTHCARE INDUSTRY ASSOCIATION (HCIA)
RESUME BOOK
Columbia Healthcare and Pharmaceutical
Management Program
CLASS OF 2019 & 2020

RÉSUMÉS
2019
5 LUCIE BARDET
JOSHUA BARRETT
IRINA BENIMOVICH
6 MARKENRY BENOIT
JIEXIN CAI
ALY CALLAHAN
7 VEDIKA CHAWLA
ANYA CLIFFORD
MAOR COHEN
8 ADITYA VIKRAM DAGA

DANIYAL HUSSAIN
CHRIS DENNEN 2020
9 ALEX ETTINGER 18 BEN ASCHERMAN 26 JOHN NIMMO
GAUTHIER DENOYELLE LESLYE BARTH MARGARET O’BRIEN
SARAH GHOSH ALEXANDRA CAMESAS MATTHEW PESESKY
10 GOKCE (GILLY) YILDIRIM 19 ZACK CAPLAN 27 ANDREA RADKE

SHARIFF GONNELLA RENO CHEN MODAK RAJ
PARISA HEMATI LAURENCE COMAN STEPHEN REIS
11 ANGELIKA KOROMVOKI 20 ALEX EFRON 28 ARMANDO RIVERA

JESSIE LAURASH ISAIAH EINZIG JOANNA ROBERTS
REBECCA LEVIN MICHELLE FERBER ERNIE RODRIGUEZ-DUMONT
12 SAMANTHA MARTIN 21 TESS FINKEL 29 ARIEL ROKITO

AMANDA NICKLIN LISEBETH FORBES TANYA ROSENBLUT
GUS NORTHROP BEN GUZIK STEPHANIE RUSINKIEWICZ
13 ALEXA PICCIOTTO 22 BRITTANY HAMLIN 30 SHRUTI SATISH

SOLOMON RAVICH PRATEEK HANDA DANIEL SCHWEBER
JUSTIN REGGI ALEXANDER HRYHOROWYCH VICTORIA SERRANO
14 HANNAH REITAN 23 DANIELLE LABARBIERA JENKS 31 EMILY STOOPLER

AUSTIN SHAW LIZA KIND AARTI TARKAR
CANDICE SU JAMIE LANDSMAN IGNACIO THOMSON
15 RON TAITZ 24 CHLOE LI 32 AMY WOODRUFF

ANAND TAMIRISA ERIK MAI MINGMING WU
NAOMI TUDHOPE KUNAL MALHOTRA LU YE
16 SHIRLEY WANG 25 EMMA MCGREGOR 33 CARLOS ZARAZUA

SHERIE ZHOU ANISHA MUKHERJEE JOSHUA ZENILMAN
ZAID MUSTAFA TIFFANY ZHAO
2 2019-2020 HCIA RÉSUMÉ BOOK

HCIA AT
COLUMBIA BUSINESS SCHOOL
The Healthcare Industry Association (HCIA) is committed to expanding opportunities
outside of the classroom for Columbia Business School students to learn about the many
segments of the healthcare industry. Working in close collaboration with the Healthcare and
Pharmaceutical Management Program, HCIA organizes a variety of activities throughout
the year. It offers members the opportunity to increase their knowledge of the healthcare
industry, expand their professional networks, learn about diverse career paths, and secure
internships, full-time opportunities, and in-semester projects.
The healthcare-related activities broaden students’ exposure to global healthcare practice
and complement the learning that occurs in the classroom. Students interact regularly with
leading industry practitioners, many of whom are alumni, through experiential learning
opportunities and programming. The following events are offered throughout the year:
n Columbia Business School Annual Healthcare Conference
n Healthcare Career Panel
n “Day in the Life” Events with select corporate partners
n Lunch and Learn Networking Events
n Alumni Networking Events
n Executive Speakers
n Treks and NYC Site Visits
HCIA members accept full-time and internship positions across the spectrum of the
healthcare industry. Many students are recruited into management development rotation
programs and functional positions (finance, marketing, business development, strategic
planning, etc.) at global healthcare enterprises and early-stage life sciences and healthcare
services companies. Students also obtain healthcare-focused positions in consulting,
investment banking, private equity/venture capital, and nonprofit organizations.
More information can be found on our website http://www.columbiahcia.com
3
HEALTHCARE AND PHARMACEUTICAL
MANAGEMENT PROGRAM
Columbia Business School’s Healthcare and Pharmaceutical Management (HPM) Program
provides students with a real-world understanding of the increasingly complex healthcare
environment. Through a multidisciplinary approach shaped by innovative course offerings,
complementary out-of-class activities, networking opportunities with industry leaders, and one-
on-one career planning/mentoring, the Program offers a dynamic learning experience focused
on the major issues affecting the global healthcare ecosystem. The HPM Program emphasizes
critical thinking and encourages the development of new approaches to address the strategic,
economic, competitive, technological, and sociopolitical challenges facing this important sector.
Healthcare courses are offered as electives (no minimum requirements) within the overall
curriculum at Columbia Business School, enabling students to tailor their coursework to their
individual needs and career aspirations.
The HPM Program offers students:
n A flexible, comprehensive, and pragmatic array of healthcare courses
n A career-focused approach to learning and professional development
n A powerful network of alumni and other healthcare business professionals
n A global perspective
n An entrepreneurial mindset
n An attractive New York City location
n Access to the world-class Columbia healthcare community
The HPM Program was established in 2006. It is currently led by Bunny Ellerin, who brings over
20 years of leadership experience in healthcare to Columbia Business School. Bunny’s diversity
of experience includes healthcare delivery, life sciences (pharma and medtech) and digital
health, giving her a broad-based knowledge of the entire ecosystem. The Program itself was
designed by seasoned industry executives who understand first-hand the skills and industry
insight necessary to be successful in this dynamic and highly challenged global business sector.
Healthcare electives build on the MBA Program’s rigorous core-curriculum and are designed
and taught by a unique mix of experienced industry executives and prominent CBS faculty.
They cover each major healthcare sector (biopharmaceuticals, medical devices and diagnostics,
healthcare services, and healthcare information technology) on a global basis, from both
industry and investor perspectives. Additionally, all functional areas are covered: strategy,
management, marketing, finance, business development, M&A, risk management, operations,
and policy.
The Program helps students successfully pursue careers in pharmaceuticals, biotechnology,
medical devices & diagnostics, healthcare services/HCIT, management consulting, investment
banking, equity research, venture capital, private equity, and entrepreneurship.
Information on the HPM Program can be found at: www8.gsb.columbia.edu/healthcare/

2019 : Bardet - Benimovich
LUCIE BARDET JOSHUA BARRETT IRINA BENIMOVICH

lbardet19@exch.gsb.columbia.edu jbarrett19@gsb.columbia.edu ibenimovich19@gsb.columbia.edu
Venture Capital and Entrepreneurship Consulting and Private Equity Venture Capital and Private Equity
Haas School of Business Georgetown University School of Medicine New York University
Berkeley, CA Washington, DC New York, NY
MBA, 2019 MD, 2021 MS, 2011
Yale University ING CAPITAL, New York, NY
Ecole de Biologie Industrielle
New Haven, CT Senior Associate, Leverage Finance
Cergy, France
BS, Molecular Cellular Developmental 2018
MSE, Master of Biotech Engineering, 2010
Biology, 2015
Originate and execute leveraged finance
GLOBAL NEUROHEALTH VENTURES,
WEILL CORNELL MEDICINE, New York, NY transactions for a $1.4B portfolio with 37
San Francisco, CA
Quality & Patient Safety Internship companies in the Healthcare Services and
Investor Intern
2018 Medical Device space.
2018 – Present
Raising firm’s $120M fund to LPs Developed and implemented institutional Prepare and deliver marketing pitches,
worldwide. Creating templates catalogue opioid prescribing policy and pain credit analysis, including financial
(contracts, contents, …). management strategy for 1,900 clinicians. modeling, due diligence and discussions
with legal counsel on transaction
Published opioid report, resource toolkit,
BEE PARTNERS, San Francisco, CA documentation.
checklist, and patient brochures to change
VC Associate Intern
physician opioid prescribing behavior. CRÉDIT AGRICOLE, New York, NY
2018
Senior Associate, Structured Finance
Screened 500+ proposals, did due CENTIVO HEALTH, New York, NY
2014 – 2017
diligence and prepared term sheets and MBA Internship
investment memos. Authored white paper 2018 Built and supported sustainable client
and compensations analysis. relationships for a $14B portfolio.
Collaborated with founding team to
MORIMATSU PHARMACEUTICALS, perform research and analysis to inform Relationship manager that contributed to
Shanghai, China provider network strategy. deal origination, live deal execution, and
Validation and Quality Manager financial due diligence.
Analyzed provider data to prioritize
2014 – 2017 national provider partners, assess Proposed and negotiated Term Sheets for
Strategic consulting to biopharma leaders coverage, and identify clients. new transactions.
building multi-million-dollar facilities. Led
interdisciplinary Chinese team of 20+. IRVING INSTITUTE FOR CLINICAL SUMITOMO MITSUI BANKING
clients included Unilever in South Africa RESEARCH, New York, NY CORPORATION, New York, NY
and Novartis in Singapore. MBA Researcher Associate, Project Finance
2017 – Present 2011 – 2014
BIOMERIEUX SHANGHAI BIOTECH,
Published journal article as lead author Maintained a portfolio for closed
Shanghai, China
in Health Affairs on value-based payment transactions including amendments,
Project Manager
programs to treat opioid addiction. administration and periodic credit reviews.
2012 – 2014
Supervised team of 10+ to quadruple Spearhead Commonwealth Fund
production capacity. publication investigating behavioral health
integration in primary care practices.
NOVO NORDISK ENGINEERING –
PHARMAPLAN, Lyon, France
Process Engineer
2011 – 2012
Conducted $24M compliance upgrade
project for Ipsen in France.
5
2019 : Benoit - Cohen
MARKENRY BENOIT JIEXIN CAI ALY CALLAHAN

mbenoit19@gsb.columbia.edu jcai19@gsb.columbia.edu acallahan19@gsb.columbia.edu
Management Venture Capital and Management Strategy and Entrepreneurship
The Pennsylvania State University Fudan University Lehigh University

University Park, PA Shanghai, China Bethlehem, PA
BS, Microbiology, 2012 BA, English and Accounting, 2010 BS, Bioengineering, 2011
BRISTOL-MYERS SQUIBB, Princeton, NJ MORNINGSIDE VENTURES, TRUVERIS, New York, NY

MBA Summer Intern – Shanghai, China MBA Intern, Product Management
R&D Strategy & Planning Healthcare Investment Intern 2018
2018 2017
Led revamp of client-facing reporting
Co-piloted a survey issued to over 580 Conducted due diligence, deal sourcing platform; reduced annual spend by 50%
senior leaders across R&D, HR, IT, and and competitive analysis for portfolio ($600K) and opened new revenue streams.
Finance to examine individual networks companies.
Bridged cross-functional stakeholders
as part of an organization-wide network
ABBOTT LABORATORIES, Shanghai, China from product, engineering, account
analysis.
Associate Product Manager management, and analytics to get buy-in
Leveraged IT usage data in conjunction 2015 – 2017 on vision.
with network analysis results to identify
Increased sales growth of promotional Made business case to license business
silos between R&D business units from a
product by 69% by adjusting distribution intelligence software after conducting
technological and cultural perspective and
channel promotion after market analysis. structured vendor evaluation, including
recommend both quick-win opportunities
prototyping new platform in two tools and
and long-term solutions. Initiated social media marketing project testing hypotheses via user research.
and achieved goal of 1000 registrations
ING CAPITAL LLC, New York, NY
six months ahead of schedule with 50% ATHENAHEALTH, Watertown, MA
Intern, Analyst, Associate
allocated budget, championing Best Digital Product Manager, Analytics
2013 – 2017
Program in Global Marketing Olympics. 2013 – 2017
Managed portfolio by forecasting draws
BOSTON SCIENTIFIC, Shanghai, China Led nine-person team of local and remote
upon and repayments of portfolio loans
Senior Professional Education Specialist engineers, user experience, and product
for budgeting purposes (working directly
2013 – 2015 associates creating new dashboard
under Infrastructure Finance team head).
application to enable customers to
Discussed with senior credit officers Spearheaded overseas doctor education monitor business performance; met alpha
various requests from clients to waive or programs by establishing SOP and goals, moving to 250-customer beta.
amend financing documentation, including collaboration with 12 host institutions.
Partnered with VP of division to define
analyses on perceived risks associated Conducted 15 domestic doctor education five-year vision and strategic execution
with clients’ proposals. programs covering 550+ doctors, advancing plan to productize company’s data asset.
Constructed financial models/analyses, clients’ concepts and skills - product usage
increased by 12 times in one case. Ran team using strategic analytics to
and presentation materials jointly with a
optimize business performance for a
VP-level team member for advisory work.
MEDTRONIC, Shanghai, China portfolio of national hospital clients; saved
Clinical Specialist / Business Trainee largest U.S. nonprofit health system $45M.
2010 – 2013
IQVIA, Waltham, MA
Performed analytical troubleshooting and Market Research Analyst, Diagnostics
patient treatment consultation through 2011 – 2012
technical support in catheter labs &
8,000+ patient follow-ups. Produced competitive analyses, financial
models, strategic appraisals, product
Built patient referral fast track from reviews, and market outlooks.
hospital unqualified to implant devices to
qualified ones, breaking regulatory barriers
for unqualified hospitals to enter market.
VEDIKA CHAWLA ANYA CLIFFORD MAOR COHEN
vchawla19@gsb.columbia.edu aclifford19@gsb.columbia.edu mcohen19@gsb.columbia.edu
Marketing and Strategy Strategy and Management Technology and Entrepreneurship
Brown University Wellesley College University of Michigan

Providence, RI Wellesley, MA Ann Arbor, Michigan
BSc, Biomedical Engineering, 2013 BA, Bioethics, 2012 BA, Organizational Studies
(Concentration: Behavioral Economics),
NOVARTIS PHARMACEUTICALS, GILEAD SCIENCES, San Francisco, CA 2012
East Hanover, NJ MBA Intern, Managed Markets Strategy
MBA Intern – US Oncology and Operations CAREDOX, New York, NY
2018 2018 Summer Operations Intern
2018
Led the design and development of a sales Informed market access strategy by
tool for the Neuroendocrine Tumors (NET) developing the first enterprise-wide Created nationally scalable processes and
franchise to assist 63 field representatives financial baseline and projections for outsourcing strategy for delivering health
in account planning and call preparation. patient support programs, mapping annual services to public schools.
costs against internal supply-chain and
Collaborated with agency partners to Designed a community-based chronic
sales data.
develop an innovative simulation exercise care management program for Medicaid
on account-targeting for annual sales Achieved buy-in from finance, brand, and beneficiaries.
meeting. patient operations teams to implement
recommendations after presenting analysis ADVISORY BOARD COMPANY,
DELOITTE CONSULTING, Houston, TX to senior leadership. Washington, DC
Consultant Senior Dedicated Analyst
2015 – 2017 ROIVANT SCIENCES, New York, NY 2015 – 2017
MBA Intern, Business Operations
Led a software upgrade for the emergency Developed initiatives to improve
2018
room application of a major health system organizational culture for health system
client in three geographic locations. Developed the business case for social clients, executing surveys and presenting
listening tools during clinical trial patient recommendations to senior executives.
Configured setup for electronic submission
recruitment and analyzed target company
of a provider’s quality data to comply with Taught leadership skills to groups of up to
for acquisition.
a federal mandate and avoid ~$10M in 2018 200 frontline managers.
Medicare fee penalties. SPREZZATURA MANAGEMENT
Senior Analyst
Spearheaded the firm’s inclusion initiative CONSULTING, Washington, DC
2014 – 2015
for 55 clinical information systems analysts. Consultant
2015 – 2017 Launched digital learning product used by
DELOITTE CONSULTING, Bangalore, India 20,000 people across 200 organizations.
Implemented a Congressionally-mandated
Business Technology Analyst
health IT modernization initiative for Won firm’s top prize for excellence in
2013 – 2015
Department of Veterans Affairs (VA) client, product and design after developing
Implemented new functionality in by managing health product development an educational mobile app in company
electronic health records of organizations and support teams through software hackathon with 15 other teams.
to streamline patient care and integrate rollout.
with third-party applications. Analyst
Identified and reduced financial waste by 2012 – 2014
Designed a new template for software 10% for client organization’s $40M budget
change control, which was adopted by the by creating data models to analyze client’s Built curriculum delivered to 2,500
client for use by a team of 200+ analysts. current vs expected personnel/software high-potential executives across different
costs and informing new contracting sectors of healthcare.
strategy. Conducted primary and secondary
research, created course materials, trained
faculty, and planned multiday conferences.
7
2019 : Daga - Ghosh
ADITYA VIKRAM DAGA DANIYAL HUSSAIN CHRIS DENNEN

avd2128@gsb.columbia.edu dhussain19@gsb.columbia.edu cdennen19@gsb.columbia.edu
Finance Venture Capital, Private Equity/Investing Private Equity, Venture Capital,
Entrepreneurship, Strategy
University of Kolkata Columbia University
India New York, NY Yale University
Bachelor of Commerce, 2000 MPH, 2015 New Haven, CT
BA History, 2012
Institute of Chartered Accountants India University of Pennsylvania
Chartered Accountant, 2002 Philadelphia, PA HEALTH ENTERPRISE PARTNERS (HEP)
BSc, Chemical & Biomolecular MBA Intern
THERMO FISHER SCIENTIFIC, Boston, MA Engineering, 2009 2017 – 2018
Senior Director Finance BA, Economics, 2009
2018 Led projects in all phases of deal life-
FLAGSHIP PIONEERING/COGEN, cycle including: sourcing, diligence, deal
Planning, Analytics and Reporting Cambridge, MBA execution, liquidation, and portfolio
Summer Associate, 2018 company and investor relations.
PHILIPS LIGHTING, Somerset, NJ
Director Finance Scientific evaluation of novel therapeutic Constructed financial model and returns
2013 – 2018 target from literature. projections for both growth equity deals
Led indication prioritization exercise for (Series A-D) and leveraged buyouts.
Managed planning & performance cadence
initial produce development.
for Lighting America’s P&L (Sales $1.8B) STRATEGY&, New York, NY
with 92% forecast accuracy. Analyzed key clinical development
Manager
trends and proposed biomarker based
Turned around declining Luminaire 2012 – 2017
development strategy.
business to +2% growth. Advisory Manager within the Heath
ASTRAZENECA, Gaithersburg, MD Industries Group in the Management
PHILIPS HEALTHCARE, Boston, MA Associate Director - ImmunoOncology Consulting practice; helped 20+ clients
Finance Business Partner 2016 – 2017 navigate and succeed within the changing
2011 – 2013
Led forecasting process and customized and challenging healthcare landscape.
Defined finance governance, control and market research to identify drivers for
Advised clients across the healthcare
reporting framework for expansion in Bladder and Head & Neck cancer drugs.
industry. Client list includes: large national
Japan, UK, and Netherlands. Conducted commercial assessments to payers, large scale provider organizations,
Identified and drove targeted acquisition guide strategic investment decisions across cancer hospitals, academic medical
process. various solid tumors. centers, digital health companies.
Implemented a >$1M process for tracking
PHILIPS MRI INVIVO, Gainesville, FL Promoted to Manager in four years, the
drug performance.
Financial Controller quickest to do so in PwC Advisory.
2009 – 2011 HURON CONSULTING, New York, NY
Manager, 2014 – 2016
Executed post-acquisition integration while
turning-around business exceeding ‘Value Led engagements across life-science
Creation’ targets. clients spanning the entire clinical
development spectrum.
PHILIPS, Netherlands and India Developed detailed business cases around
Various Finance Roles acquisition targets.
2002 – 2008
FRANKEL GROUP, New York, NY
Internal Audit - planned, organized,
Consultant
executed audit assignments globally.
2009 – 2013
Finance Shared Center (FSC) - supported Developed commercialization, business
designing, building & testing, implementing development, pricing & life cycle
and roll out of the captive FSC. strategies.

ALEX ETTINGER GAUTHIER DENOYELLE SARAH GHOSH
aettinger19@gsb.columbia.edu gdenoyelle19@gsb.columbia.edu saghosh19@gsb.columbia.edu
Management and Strategy Strategy and Data Analytics Med Tech, Pharmaceuticals and Biotech,
Venture Capital
University of Pennsylvania Ecole Centrale Paris
Philadelphia, PA Châtenay-Malabry, France University of Chicago
BSE, Bioengineering, 2012 BS, MSc, Industrial Engineering, Chemistry, Chicago, Illinois
2013 AB, 2011
PFIZER INC, New York, NY
Marketing Summer Associate, 2018 ROLAND BERGER, TRUVERIS, New York, NY
Identified opportunities and Paris, France and Milan, Italy Manager of Patient Access, Life Sciences
recommended strategies to grow Senior Consultant 2018
CHANTIX® revenue in over 300 hospital 2013 – 2017
Developed innovative patient copay
systems. Worked on 25+ strategic (due diligence, benefit design for a cardiovascular drug
Created six marketing pieces to drive business review & planning) and utilizing in-house pharmacy technology and
HCP awareness of revised Department of operational projects (supply chain data analytics.
Transportation policy. optimization, procurement transformation,
Advised pharmaceutical clients on drug
cost reduction), of which 60-70% were in
pricing and yearly planning.
JDS THERAPEUTICS, Purchase, NY Healthcare and Life Sciences.
Brand Manager, 2015 – 2017 Led the business and technology
APPLE, Paris, France development of a pilot program for an
Assistant Brand Manager, 2014 – 2015 Data Science Intern ophthalmologic implant’s patient access
Led cross-functional Product Development 2012 program, growing program revenue 200%
Team to guide new product investments Administered geo-marketing statistical and managing 700+ physician offices.
based on market research, regulatory analyses and opportunity assessment
pathway evaluation, supply chain and HAVAS HEALTH, New York, NY
studies to support Apple retail network
manufacturing, and IP analysis. Director of Strategy
development.
2016
Directed marketing activities for products
STANFORD UNIVERSITY, Palo Alto, CA Served as marketing and strategic advisor
RELIZEN® and SERENOLTM®, resulting in
Visiting Researcher – ZareLab to Top 5 Pharmaceutical Company’s
141% increase in sales from previous year.
2011 Oncology brands.
Coordinated and executed launch of
Performed research focused on controlled Designed multiple competitive planning
SERENOLTM® and correspondingly
release of mRNA from PLGA nanoparticles workshops for Oncology clients in
collaborated with Executive Team to
for gene therapy delivery. preparation for 2016 and 2017 American
implement go-to market strategy for
national sales force. Society of Clinical Oncology Conferences.
Analyzed Phase II and III oncology clinical
SIMON-KUCHER & PARTNERS, New York, NY
trial data to determine competitive
Consultant, 2012 – 2014
advantages and develop pre and post-
Delivered actionable recommendations to launch plans.
six of the top ten global pharmaceutical
companies across variety of indications STRATEGY&, New York, NY
including: oncology, neurology, Senior Consultant, Pharma/Life Sciences
interventional cardiology, and Commercial Strategy
endocrinology. 2011
Created comprehensive commercial Developed 3-year U.S. prelaunch plan for

readiness program for a global Top 5 Pharma client’s biosimilar infliximab.
pharmaceutical company’s lead ovarian Executed a “beyond-the-pill” service
cancer compound by conducting robust expansion plan for Top 5 Pharma’s in-house
primary research across the US, EU-5, and specialty pharmacy.
Japan.
9
2019 : Yildirim - Levin
GOKCE (GILLY) YILDIRIM SHARIFF GONNELLA PARISA HEMATI

gyildirim19@gsb.columbia.edu sgonnella19@gsb.columbia.edu phemati19@gsb.columbia.edu
Entrepreneurship and Strategy Management and Strategy Precision Medicine and Genomics Testing
Columbia University Embry-Riddle Aeronautical University Sarah Lawrence College

New York, NY Daytona Beach, Florida New York, NY
MSc, Biomedical Engineering, 2004 MS, Safety Systems and Management, 2004 MS, Human Genetics, 2015
BS, Business Administration in Aviation, 2002
New Jersey Institute of Technology University of British Columbia
Newark, NJ CARGOLUX AIRLINES, Houston, TX Vancouver, BC
BSc, Industrial Engineering, 2003 Central/South America Business BS, 2013
Development Manager
STRYKER, Mahwah, NJ 2018 – Present INSTITUTE FOR GENOMIC MEDICINE,
Senior Staff Development Engineer COLUMBIA UNIVERSITY, New York, NY
2013 Route Manager – The Americas Genetic Counselor
2015 – 2018 2017
Generated big-data analytics models for
human bone density assessment in robotic North America Led global project focused on gene
surgery resulting in multiple patents. Business Development Manager discovery, resulted in collaboration with
2014 – 2015 more than 15 medical institutions.
Generated business strategy reports for
implant product portfolio. Led all sales and marketing activities, Managed referrals to diagnostic
strategy formulation, business sequencing research study by reviewing
PIPELINE, Cedar Knolls, NJ development, legal, and operational medical records, interviewing candidates,
Senior Research Engineer overview of the region. and determining eligibility, resulted in
2011 - 2013 enrolling more than 100 families into
Hold full P&L responsibility for sales
Tested and cleared implantable medical & operations through direct training, studies in the new research institution.
devices through the FDA. leadership, and supervision of the 6 Analyzed identified genetic variants to
independent General Sales Agents determine pathogenicity by conducting
Designed and tested early concept robotic
organizations comprised of 15 sales extensive scientific research, researched
surgery implants using titanium additive
representatives across LATAM territory. more than 500 genes.
manufacturing resulting in multiple
patents. Represent the company views at Ran monthly meetings with leadership
negotiations as a member of government team to present recommended diagnosis
NYU LANGONE MEDICAL, New York, NY delegations. for each patient based on my research,
Research Engineer
resulted in diagnosis for more than 50
2004 - 2011 LATIN LINK LOGISTICS LLC, Miami, FL
patients.
Co-Founder & Managing Director
Partnered with surgeons and medical
2011 – 2014
device manufacturers for implant concept
design tests. Founded a Freight forwarder / NVOCC
(full-scale operational set-up). Carried out
Designed test machinery for orthopaedic
full-scope responsibility for operations,
implant testing.
financial management, policies,
procedures, strategic planning, technology,
and sales/marketing.
Managed all sales activities and was in
charge of increasing performance through
creative and selective service capabilities
to become a significant player in the Latin
America logistic.

ANGELIKA KOROMVOKI JESSIE LAURASH REBECCA LEVIN
akoromvoki19@gsb.columbia.edu jlaurash19@gsb.columbia.edu rlevin19@gsb.columbia.edu
Entrepreneurship and Private Equity Private Equity and Venture Capital Consulting and Management
King’s College London Georgetown University Columbia Business School

London UK Washington, DC Columbia Mailman School of Public Health
BSc, Business Management, 2013 BS, Biology, 2011 New York, NY
MBA/MPH, 2020
PHARMATHEN S.A., Athens, Greece HEALTH ENTERPRISE PARTNERS,
Business Development Manager New York, NY COREPOWER YOGA, Denver, CO
2014 – 2017 MBA Intern Chief of Staff to CEO and CFO
2017 – Present 2015 – 2017
Responsible for out-licensing the
company’s dossiers of generic molecules in Evaluate investment opportunities, Led overhaul of annual liability insurance
a number of European countries. conduct financial, market, and renewal process by organizing cross-
company due diligence, model returns functional team to budget accurate
Developed and executed commercial
scenarios, and communicate investment construction costs, studio-level
strategy for countries of responsibility.
recommendations. performance, and SG&A leading to
PHARMATHEN Hellas, Athens, Greece accurate forecasting via systematic
Produced strategic growth assessment and
Product Manager for NUXE cosmetics reporting mechanism.
identified go-to-market opportunities for
2013 – 2014 portfolio company. Streamlined studio supply ordering by
Developed and executed marketing analyzing order history and standardizing
MEDIQUIRE, New York, NY order process through collaboration with
strategy of NUXE Greece.
Director of Operations studio management.
Designed, implemented, and analyzed 2016 – 2017
promotional campaigns for existing Developed customer incident dashboard
Developed and managed initial operating for studio management with an automatic
products and led new product launches.
model and company-wide key performance decision tree that initiated remedial
indicators across all functional teams. actions and consolidated incident trends
Managed product delivery and to inform policy changes.
implementation for all health center
O2 ASPEN, Aspen, CO
clients.
Account Manager,
EVOLENT HEALTH, Arlington, VA Retail Accounts and Yoga Membership
Associate Director 2013 – 2014
2014 – 2016 Increased client retention by instituting
Identified and analyzed opportunities to customer and staff feedback channels and
partner with leading health systems to analyzing seasonal purchasing history
support their value-based care businesses.
ASPEN VALLEY FOUNDATION, Aspen, CO
Developed business plans for Medicaid Program Assistant
and Practice Optimization technology and 2012 – 2013
service offerings.
Implemented new community-facilitated
BOOZ ALLEN HAMILTON, Washington, DC Suicide Prevention Training that has since
Senior Consultant grown to multiple counties and trains
2011 – 2014 1,000+ community members annually.
Provided project management support

to the Department of Health and Human
Services and its implementation of the
health insurance exchange program.
11
2019 : Martin - Reggi
SAMANTHA MARTIN AMANDA NICKLIN GUS NORTHROP

smartin19@gsb.columbia.edu anicklin19@gsb.columbia.edu anorthrop19@gsb.columbia.edu
Private Equity and Real Estate Marketing, Management Pharmaceutical & Biotech LDPs,
Marketing and New Product Planning
Georgetown University Cornell University College
Washington, DC of Veterinary Medicine, Ithaca, NY Oxford University
BS, Human Science, 2013 DVM, 2014 Oxford, UK
BA Medical Sciences, 2011
PFIZER, INC., New York, NY Rensselaer Polytechnic Institute
MBA Summer Associate Troy, NY BIOMARIN, San Francisco, CA
2018 BS, Biology, 2010 Pipeline Commercialization MBA Intern
2018
Developed go-to-market strategy for new CELGENE, Summit, NJ
Pfizer Direct home delivery e-commerce MBA Summer Intern Market planning and pipeline marketing for
platform, determining key performance 2018 Phase 3 Hemophilia A gene therapy.
indicators, expanding product offerings, Managed planning and execution of KOL
and forecasting $10M in incremental Led brand-wide, cross-functional
and Patient Advocate Advisory Board (>20
revenue. brainstorming workshop to develop
attendees).
positioning of initiation support services
Identified optimally balanced channel mix & presented recommendations to senior Analyzed patient survey data to segment
for targeted marketing to effectively reach leadership. and profile early adopters.
key provider and patient populations.
Engaged with colleagues, vendors, and GLOBE LIFE SCIENCES, London, UK
SUPPORTIV, INC., New York, NY external technology firms to develop Consultant, 2017
MBA Product Strategy Intern implementation strategy for technology
Promotion to most senior non-partner
solution.
Conducted pre-launch market grade before MBA.
research to develop go-to-market and ANIMAL EYE GUYS, Fort Lauderdale, FL Senior Analyst, 2014 – 2017
commercialization strategies. Ophthalmology Specialty Intern
2015 – 2016 Led ‘war-gaming’ workshop with cross-
Projected market demand and forecasted functional executives at top 10 pharma to
revenue estimates based on proposed Examined and developed appropriate modify $370M brand’s strategy prior to
pricing methodologies. diagnostic and therapeutic plan for competitor launch (annualization of this
approximately 30 patients per day. exercise).
DELOITTE LLP, New York, NY
Consultant, US Strategy Led revision of medical templates Modeled biotech’s pipeline ($500M rNPV),
2015 – 2017 to increase doctor efficiency and with valuation underpinning 3 pharma
comprehensiveness of medical records. collaborations ($200M upfront, >$5B
Business Analyst, US Strategy
potential milestones).
2013 – 2017 ANIMAL MEDICAL CENTER, New York, NY
Small Animal Medicine Business Analyst, 2013 – 2014
Developed future revenue opportunity
model to estimate clients’ professional and Surgery Rotating Intern Designed and delivered quarterly
services spend, identified $300M 2014 – 2015 competitive intelligence reports for $750M
incremental opportunity across Deloitte’s Prioritized care of most critically ill franchise at top 10 pharma, leading to
core and adjacent markets. patients and delegated treatments to project renewal and top consultancy
facilitate rapid flow through emergency ranking in 2014.
Partnered with data analytics start-ups to
build cognitive technology-powered risk room. Completed market and product
assessment platform for financial services assessment of biotech’s lead Phase II
Collaborated with and presented cases to
clients, developed use cases for testing program, with forecast underpinning
more than 60 board-certified specialists
hypotheses on novel datasets. negotiations in $650M pharma acquisition
and residents in care of hospitalized
($200M upfront).
Created business cases recommending patients.
$10M+ investments in Life Sciences Research Analyst, 2012 – 2013
practice, resulting in 30% increase of Fast-track promotion to Business Analyst
projected annual revenues by 2020. (<1 year).

ALEXA PICCIOTTO SOLOMON RAVICH JUSTIN REGGI
apicciotto19@gsb.columbia.edu sravich19@gsb.columbia.edu jreggi19@gsb.columbia.edu
Healthcare, Strategy and Operations Management Consulting Technology and Strategy
Columbia Business School & Mailman School University of Michigan - University of Pennsylvania
of Public Health, New York, NY Ross School of Business, Ann Arbor, MI Philadelphia, PA
MBA & MPH, 2019 BBA, Strategy, 2012 BA, Biological Basis of Behavior, 2012
University of Maryland THE BOSTON CONSULTING GROUP MOUNT SINAI’S LAB100, New York, NY
College Park, MD (BCG), New York, NY In-Semester Fellow
BS, Marketing 2013 Consultant Fall 2018
2018
MEMORIAL SLOAN KETTERING CANCER Developing strategic partnership and
Developed best-in-class guidelines for monetization strategy for Mount Sinai’s
CENTER, New York, NY
regulatory change controls and regulatory Lab100, a hybrid clinic and lab that
MBA Intern, Operations Strategy
implementation with local health- leverages technology and data to redesign
2018
authorities as part of integration of $17B ways to measure health and deliver care.
Managed the evaluation of pharmacy pharmaceutical with global distribution of
supply chain to streamline purchasing sterile injectables. MEDIDATA SOLUTIONS, New York, NY
approvals, assess demand, and improve Product Marketing MBA Intern
vendor contract terms. GOLDMAN SACHS, New York, NY
Summer 2018
Management & Client Strategy
Analyzed patient discharge data and 2014 – 2017 Collaborated across marketing, product,
observed hospital floor workflows to and sales teams to develop marketing plan
implement improvements to reduce Designed and led market share growth
and GTM assets for new data analysis and
discharge time by 9.7%. initiative across 500+ sales members,
professional services offering and increase
conducting competitive analysis and client
CLV of software-only customers.
MONTEFIORE HEALTH SYSTEM, segmentation to identify potential revenue
New York, NY of $150M+ over three years. Created customer segmentation
MBA Intern, Strategic Planning framework to prioritize highest
Led team of six across Sales, Legal, and
2018 opportunity targets and translated
Technology to design commercialization
Helped build service line strategies for customer behavior into data-driven digital
strategy, resulting in $3m+ revenue growth.
obstetrics department. marketing campaign.
Conducted study of 25+ investment firms
Developed market assessments to to develop accountability framework to BLUEPRINT RESEARCH GROUP,
determine strategic opportunities for respond to client feedback, generating New York, NY
clinical expansion. $2m+ growth in sales revenue. Senior Consultant
2012 – 2017
MINDSHARE, New York, NY ADVISORY&, New York, NY
Manager, Media Strategy Senior Associate Consultant Managed client relationships and led
2017 2012 – 2014 insight development for product launch
and marketing strategy projects for life
Managed $30M+ media campaigns for Directed team of three consultants and six sciences companies including Roche/
Unilever and American Express clients. developers as project testing lead for sales Genentech, Amgen, AstraZeneca, and
Prepared a weekly competitive landscape and trading software, resulting in improved Allergan.
update of the haircare category for throughput rates.
Opened London office with Associate
Unilever clients that informed media Trained 30+ clients on IT procedures, Partner, winning and managing $8M in EU-
strategies. leveraging client insights and industry based project work in 2016-2017.
leading metrics to strengthen cyber
security, resulting in cost savings of $10m. Founded pro bono arm of company by
spearheading partnership with non-profit
Awarded “Rookie of the Year” honors for organization Solving Kids’ Cancer.
outstanding client service.
13
2019 : Reitan - Tudhope
HANNAH REITAN AUSTIN SHAW CANDICE SU

hreitan19@gsb.columbia.edu ashaw19@gsb.columbia.edu csu19@gsb.columbia.edu
Marketing and Strategy Strategy and Management Corporate Finance and Operation
University of Michigan Columbia Mailman School of Public Health Columbia Business School
Ann Arbor, MI New York, New York New York
BA, History and International Studies, 2013 MPH, 2019 MBA, 2019
PFIZER INC, New York, NY University of North Carolina at Chapel Hill MERCK & Co., Kenilworth, NJ
Summer Associate, Marketing Chapel Hill, NC Summer Treasury Intern
2018 BA, Economics, 2013 2018
Applied behavioral economic concepts HOSPITAL FOR SPECIAL SURGERY, Made recommendations to improve
and market research findings to enhance New York, NY Merck Shares Repurchase Program by
key consumer marketing tactic for vaccine Pre-MBA Strategy Intern modeling various pricing methodologies;
adherence. 2013 recommendations are adopted by
company’s Treasurer and implemented by
Conducted market research with 250+
JOHNSON & JOHNSON end of internship.
parents to test new creative concepts for
Medical Device Marketing MBA
vaccination reminder postcards. ASUS, Taipei, Taiwan
Summer Associate
2018 Controller of Sales and Marketing
DELOITTE CONSULTING, Chicago, IL
2015 – 2017
Consultant, 2016 – 2017 Developed a marketing strategy refresh for
Business Analyst, 2014 – 2016 a $50M medical device within the Ethicon Doubled APAC regional profit in one year
Biosurgery product suite. by providing P&L simulations and analytical
Created strategic vision for Fortune
insights for partnering sales and marketing
100 pharmaceutical company’s contract
HOSPITAL FOR SPECIAL SURGERY, managers; monitored $1.5B annual revenue
manufacturing business; interviewed
New York, NY for 14 countries in APAC region.
executives, launched and analyzed
Pre-MBA Strategy Intern
employee survey, and presented findings Controlled $50M annual marketing budget
2013
to senior leadership. and allocated to branches strategically;
Developed dynamic dashboards for served as sole APAC representative to
Managed design of global operating
C-Suite to analyze regional markets, communicate headquarters profit strategy
model for $500M joint venture between
patient geography, and competitive market to overseas sales managers and sales force.
Fortune 500 medical device company and
share.
private equity firm; worked with VP-level ASUS, Taipei, Taiwan
clients in finance and supply chain to build DELOITTE CONSULTING, McLean, VA Finance Analyst
operational process flows, draft contracts, Consultant, Strategy & Operations 2014 – 2015
and prepare staff for organizational 2015 – 2017
changes. Increased $4M profit in 2 years by
Worked across provider space to conduct optimizing operation process between
Analyzed customer data sets for medical outpatient and competitive analysis and sales team and accounting department.
device company’s $24M product line build financial models for C-suite clients to
integration; built model to monitor sales monitor implementation of newly adopted ERNST & YOUNG, Taipei, Taiwan
and prioritized field force outreach to help strategic initiatives. Auditor
client exceed goal of retaining 70% of pre- 2012 – 2014
acquisition revenue. Led teams of data scientists, designers,
and developers to apply design thinking Conducted analytical procedures to
Led trainings for nine functional and transform big data into user-friendly detect unusual trends or periodic
departments and conducted vendor prototypes for multiple clients through a variances in financial statements.
coordination for launch of software Deloitte Analytics Fellowship.
product to streamline management of
$100M in accounts receivable for regional Established global reporting processes to
hospital system. track execution of new finance activities
across all locations globally for two major
pharmaceutical companies.

RON TAITZ ANAND TAMIRISA NAOMI TUDHOPE
rtaitz19@gsb.columbia.edu atamirisa19@gsb.columbia.edu ntudhope19@gsb.columbia.edu
Strategy and Technology Finance and Consulting Corporate Development and Strategy
Yale University University of Texas at Austin Wesleyan University

New Haven, CT Austin, TX Middletown, CT
BA, Economics, 2015 BBA, 2012 BA, East Asian Studies, 2011
CONSENSYS INC., Brooklyn, NY HOUSTON CENTER FOR CLINICAL ADVANCE, New York, NY
Galileo Strategy Intern RESEARCH, Houston, TX MBA Intern, Corporate Development &
2018 Director of Operations Strategy
Led the initiative to identify and design 2016 - 2017 2018
the most viable and lucrative blockchain Created multi-million dollar budgets Conducted due diligence for multi-billion
solution specifically targeting the for trials with major pharmaceutical dollar capital deployment initiative.
inefficiencies of the pharmaceutical companies, including Bayer, Allergan, and Developed go-to-market strategy to
industry. AbbVie. differentiate Advance in competitive
Researched and analyzed competitor Managed staff of seven and recruited marketplace.
strategies and made recommendations to physicians and certified medical assistants
senior management. to conduct clinical trials. BRUNSWICK GROUP, Shanghai, CN
Account Director
Increased projected revenue by $1.5M by
BANK OF NEW YORK MELLON, 2015 – 2017
bidding for and winning over 15 clinical
New York, NY
trials for various health conditions. Developed and implemented
Senior Associate
2016 – 2018 comprehensive communication and
QUORUM BUSINESS SOLUTONS, stakeholder engagement strategies for
Led the BNY Mellon Blockchain Client Houston, TX clients during business critical moments
Engagement Initiative, which reconciled Senior Consultant affecting reputation and valuation.
client demand for blockchain-based 2012 – 2016
solutions with the capacity constraints EMERGING STRATEGY, Shanghai, CN
Directed a budget for the management
faced by our blockchain solution Consultant
of wind turbines in 10 states that reduced
development team. 2014
data retrieval time by 10% and simplified
Directed client engagement strategy to report generation for daily business Oversaw the company’s largest
capitalize on knowledge of the clients and operations among client Land, GIS, and engagement, global market assessment for
on insights into industry trends to win reporting teams. a leading educational testing company.
additional mandates, particularly in the Pitched mapping solution to Land
CLO and non-performing loan servicing Management team (responsible for North GBI, Shanghai, CN
space. America assets); awarded $10,000 to Content Marketing & Corporate
implement. Communications Specialist
SYNPULSE MANAGEMENT CONSULTING, 2013 – 2014
New York, NY Developed and customized applications
Associate Consultant per user needs by partnering with client Created GBI’s first marketing strategy
2015 – 2016 Land/GIS team leads. for growing product portfolio of market
intelligence and mobile applications for
Performed market analysis focusing on China and Brazil’s healthcare industries.
demand and competition through market
sizing and revenue estimations,which
PFIZER, New York, NY
identified key market entry points for
International Public Affairs Consultant
Synpulse’s FinTech-centric consulting
2011 – 2012
services.
Evaluated government regulations and
developed stakeholder engagement
strategies to influence operating
environment.
15
2019 : Wang - Zhou
SHIRLEY WANG SHERIE ZHOU

shwang19@gsb.columbia.edu szhou19@gsb.columbia.edu
Business Analytics, Health Tech and Providers Strategy and Consulting
Columbia Mailman School of Public Health University of Virginia

New York, NY Charlottesville, VA
MPH, Health Policy & Management 2019 BS, Biology, 2014
Princeton University STRATEGY&, New York, NY

Princeton, NJ Senior Associate Intern
BA, Economics, 2015 2018
WELLTHIE, INC., New York, NY Assessed physician and hospital landscape

Data Intern for a pharmaceutical drug launch, and
2018 developed actionable insights to optimize
salesforce deployment at 150 key hospital
Researched the competitive landscape accounts.
of health insurtech data capabilities,
evaluated competitive advantage, and Evaluated competitive landscape and
identified third-party data sources to brainstormed the future state for a
bolster Wellthie’s data capabilities. company entering the healthcare data
market.
Developed a strategy for future data
projects and created proof of concept NSF INTERNATIONAL, Washington, DC
examples related to risk analysis, Associate Practice Manager
predictive analytics, and decision support 2017
for Wellthie’s clients.
Drove client engagements by developing
COVANCE, INC, Princeton, NJ proposals, forecasting budgets, negotiating
Data Analyst II contracts with VPs and Directors, and
2015 – 2017 creating supplemental documents to help
clients obtain project approvals from the
Analyzed clinical trials budgetary data to C-suite.
improve pricing algorithms and margin
calculation for more accurate multi-million- Evaluated two acquisition targets,
dollar budgets. developed corrective action and
integration plans with client, and
Partnered with pricing team and other resolved 59 regulatory and manufacturing
stakeholders in different departments deficiencies to improve cardiac device
to develop tools to programmatically safety. Managed ten engineers across
generate budgetary documents and create three sites.
data visualization dashboards.
NSF INTERNATIONAL, Washington, DC
Research Associate
2014 – 2017
Led strategic planning presentation to
firm’s senior management on industry
trends, lead generation, and proposal
success rates. Suggested increased
thought leadership which resulted in
133% more leads for combination product
support (2015 to Q2 2017).

17
2020 : Ascherman - Coman
BEN ASCHERMAN LESLYE BARTH ALEXANDRA CAMESAS

bascherman20@gsb.columbia.edu lbarth20@gsb.columbia.edu acamesas20@gsb.columbia.edu
Healthcare Entrepreneurship Consulting and Private Equity Management and Marketing
and Venture Capital
Vanderbilt University Brown University
Columbia University College Nashville, Tennessee Providence, Rhode Island
of Physicians and Surgeons Economics and Corporate Strategy, 2015 BA, Business, Entrepreneurship and
New York, NY Organizations, 2014
MD, 2020 BANK OF AMERICA MERRILL LYNCH,
New York, NY CATALYST @ HEALTH 2.0, Brooklyn, NY
Harvard College Investment Banking Senior Analyst, Associate Director, 2017 – 2018
Cambridge, MA Mergers and Acquisitions Sr. Program Manager, 2017 – 2017
BA, Biology (Economics minor), 2014 2017 – 2018 Program Manager, 2015 – 2017
NY PRESBYTERIAN HOSPITAL, Analyzed opportunities for divestitures, Directed team of five in the management
New York, NY leveraged buyouts, bolt-on acquisitions, of commercialization programs that
Researcher, 2014 – 2015 and transaction financings for public and facilitated partnerships between digital
private companies in industries such as health startups and enterprise healthcare
Developed rodent model to further study healthcare, technology and consumer. firms.
ECMO and analyze its impact on multiple
Prepared clients for M&A execution Led market-access program for proven
physiologic parameters.
process including the creation of technology companies looking to grow
Consented patients and collected tissue marketing materials and development of their business in the Indian healthcare
samples for studies of serum protein levels operating and pro forma financial models market.
in patients with aortic stenosis, and in for diligence.
patients undergoing treatment for aortic Evaluated 330 health tech companies from
Negotiated concurrent merger agreements
aneurysms, hypertrophic cardiomyopathy, 29 countries, resulting in the selection of
and liaised with clients, outside legal
and end-stage heart failure. 22 pilots to test solutions in the Indian
counsels and public company business
market, delivering care to 24,000 patients
NATIONAL INSTITUTES OF HEALTH (NIH), development teams.
across 80 clinical sites.
T35 RESEARCH GRANT
BANK OF AMERICA MERRILL LYNCH, Analyzed tech pilot outcomes along with
New York, NY
New York, NY data on company growth, commercial
Researcher, 2016
Investment Banking Analyst, Global contracts and funding to generate insights
Worked in Columbia University Medical Industrials Group on program success; Presented findings
Center’s Department of Orthopedic 2015 – 2017 and recommendations to client to inform
Surgery to develop predictive model of expansion of the program to a new
functional outcomes after surgical and Completed 15+ M&A processes and debt/
emerging market.
nonsurgical treatments of distal radius and equity financings for large-cap industrial
ankle fractures. companies. DIGITASLBI, New York, NY
Performed industry benchmarking and Account Executive
PITANGO VENTURE CAPITAL competitive landscape analyses on 2014 – 2015
Herzilya, Israel business services and chemicals sub-
Summer Intern, 2013 Defined strategy for personalized
verticals for weekly client distribution.
marketing campaign for $5B branded
Worked with one of Pitango’s biotech medication aimed at healthcare
portfolio companies to search for and professionals, based on the physician
establish new areas of market penetration journey, historical data, customer behavior
for novel product. and segmentation.
Researched and analyzed market potential,
Collaborated with leadership team to
growth opportunities, competition,
develop tech partnership strategy for a
differentiation, and executive teams of
patient-centered platform that promotes
biotech companies as potential investment
preventive health measures for better
opportunities.
outcomes.

ZACK CAPLAN RENO CHEN LAURENCE COMAN
zcaplan20@gsb.columbia.edu zchen20@gsb.columbia.edu lcoman20@gsb.columbia.edu
Strategy and Venture Capital Business Development Technology and Entrepreneurship
and Corporate Strategy
Boston College University of Pennsylvania
Chestnut Hill, MA Case Western Reserve University Philadelphia, PA
BS, Finance and Economics, 2014 New York City, NY BS, Economics with Finance Concentration
MS, Operations Research, 2014 at The Wharton School, 2013
INNOVATION & DIGITAL HEALTH BA, International Studies and Hispanic
ACCELERATOR – BOSTON CHILDREN’S Guangzhou University Studies (double major) at the College of
HOSPITAL, Boston, MA Pre-MBA Fellow Guangzhou, China Arts and Sciences, 2013
2018 BS, Industrial Engineering Research, 2014
VECTOR CAPITAL, San Francisco, CA
Performed due diligence on eight
SANDOZ, A NOVARTIS DIVISION, Private Equity Investment Associate
Accelerator applicants, including analyzing
Princeton, NJ 2016 – 2018
each company’s business model, team
Senior Manager, Strategic Insight
member experience, market opportunity, Evaluated investment opportunities in
and Analytics
competitive landscape, and product enterprise software companies through
2018 - Present
roadmap. financial modeling and extensive due
Supported traditional pharmaceutical diligence.
Partnered with three pre-seed digital
and digital asset commercial launch
health startup founders to develop go- Executed over $300M of add-on
(commercial due diligence, payor
to-market strategies, including defining acquisitions for two portfolio companies,
research, HCP/patient research and
pricing models, establishing key metrics, working closely with executive teams on
segmentation, and FF sizing & targeting).
identifying resource requirements, and financial modeling and due diligence.
determining fundraising targets. Drove operational excellence projects to
Led customer retention and acquisition
align with strategic imperatives (e.g. IDN
DELOITTE CONSULTING, LLP – STRATEGY analyses to optimize portfolio companies’
contracting process & market intelligence
& OPERATIONS, Boston, MA go-to-market strategies.
reporting platform).
Consultant, 2016 – 2018
Led external consultants/cross-divisional GREENHILL & CO., LLC, New York, NY
Business Analyst, 2014 – 2016
team on analytics and brand insights Senior Analyst
Advised integration of eight newly projects. 2013 – 2016
acquired hospitals, including working
First analyst in firm history promoted to
directly with each acquired hospital’s Analyst - Manager, Pricing Analytics
third-year role.
CEO and CFO to identify strategic 2014 - 2018
opportunities and define financial Led two-month global analyst and
Led cross-functional team and external
targets. Project managed five teams for associate training program.
consultants to build decision support
the system’s subsequent purchase of 18
platform. Executed M&A, buyout and strategic
hospitals.
advisory transactions across a variety of
Managed pricing for over $1B customer
Established a centralized measurement, sectors.
portfolio with hands-on experience
monitoring, and reporting structure for
running analytics for deal designing and
a non-profit healthcare system with 100+
customer negotiation.
hospitals operating in 17 states to track
cost saving initiatives against a system-wide Managed launch projects (evaluate
turnaround goal of $800M. pipeline asset and design launch/pricing
strategy) as pricing liaison.
Conducted revenue cycle assessments
for a four-hospital university healthcare Established price increase algorithm and
system, a 700+ bed New York hospital, processes for the US generic market.
and a national for-profit oncology hospital
system. Quantified opportunities resulted
in implementation projects.
19
2020 : Efron - Guzik
ALEX EFRON ISAIAH EINZIG MICHELLE FERBER

aefron20@gsb.columbia.edu ieinzig20@gsb.columbia.edu mferber20@gsb.columbia.edu
Finance and Corporate Development Finance Technology and Management
Pomona College Cornell University Northwestern University

Claremont, CA Ithaca, NY Evanston, IL
BA, Neuroscience, 2011 BS, Biology & Society, 2012 BS, Material Science and Biomedical
BS, Applied Economics, 2012 Engineering, 2015
ARBITER PARTNERS, New York, NY
Summer Research Analyst MADRYN ASSET MANAGEMENT, EPIC SYSTEMS CORPORATION,
2018 New York, NY Verona, WI
Associate Technical Coordinator
Performed business valuations, merger
2015 – Present 2016 – 2018
analyses, competitive and industry
research for various life science, Acted as part of founding team as entity Managed client relationship with Hospital
technology, and healthcare services spun out of Visium Asset Management and for Special Surgery IT team, supporting
companies. sole associate on >$170M of investments customer teams across clinical, revenue
across customized debt and equity and scheduling applications.
AARETE, New York, NY structures within specialty pharma,
Manager Led strategic planning initiative to improve
diagnostics, and device investments.
2015 – 2018 patient engagement through enhancing
Attend conferences and interact with patient portal functionality.
Directed consulting engagements in CEO/CFO teams to source and evaluate
strategy, data analytics, and profit & investment opportunities. Technical Services
operations improvement for leading 2015 - 2018
managed care organizations and Onboarded, trained, and managed two
junior associates. Provided clinical application support
healthcare systems.
to hospital clients by conducting
Led initiative to improve clinical outcomes Consult 10 hours a week while in school. weekly meetings with client analysts
and achieve $3M in annual savings for a covering training, troubleshooting, and
MTS HEALTH PARTNERS, New York, NY
Fortune 100 Medicaid MCO’s national enhancement requests resulting in
Analyst
organ transplant program. increased provider satisfaction.
2014 – 2015
Reengineered the systems and processes Coordinated health information exchange
Sole analyst on $275M of private financings
underlying revenue, claims, and reporting performance across Epic customers to
and $200M royalty monetization.
for a regional health plan, rectifying meet regulatory programs requirements.
financial and regulatory deficiencies. Constructed financial valuation models
Streamlined process to review physician
including discounted cash flow, private
HURON CONSULTING GROUP, and nurse efficiency data for hospitals and
placement capitalization, royalty
New York, NY provide recommendations.
monetization, accretion/dilution, and
Associate mergers and acquisitions analyses. CENTER FOR INNOVATION AND
2011 – 2015
GLOBAL HEALTH TECHNOLOGIES
IMS CONSULTING GROUP,
Delivered consulting solutions in Evanston, IL
New York, NY
operations, strategy, and regulatory Research Assistant
Consulting Analyst
compliance for pharmaceutical and 2012 – 2015
2012 – 2014
medical device companies.
Optimized precision and performance of
Created and implemented global pricing
Designed and implemented process an extraction process and assay as a low
and market access strategies.
improvements and fair market valuation cost, point-of-care nucleic acid test for
(FMV) models to develop global payment Advised on clinical trial design, value Multi-Drug Resistant Tuberculosis.
structures for healthcare professionals, messaging, health economic studies, and
wholesale distributors, specialty pipeline prioritization.
pharmacies, and GPOs.

TESS FINKEL LISEBETH FORBES BEN GUZIK
tfinkel20@gsb.columbia.edu lforbes20@gsb.columbia.edu bguzik20@gsb.columbia.edu
Management Consulting and Strategy Entrepreneurship, Technology and Finance
Columbia University Cornell University University of Pennsylvania

New York, New York Ithaca, NY Philadelphia, PA
BA, 2010 BA, Genetics and Classics, 2013 BA, Health and Societies, 2014
THE KINETIX GROUP, New York, NY PwC, New York, NY MERCER, New York, NY
Senior Director Manager Associate
2017 – 2018 2018 2014 – 2018
Managed European headquarters in Managed operational transformation Consulted large clients on healthcare
Dublin, Ireland ensuring full compliance at US Department of Veterans Affairs - strategy including medical, prescription
with Irish revenue and business authorities, Office of Community Care, including a drugs, vision and wellness benefits.
establishing transfer pricing protocols, and full process redesign of core business
Forecasted healthcare costs analyzed key
implementing cross-office workflows. functions (eligibility, authorization, care
areas of healthcare spend and proposed
management, provider payment, member
Conducted competitive landscape solutions to mitigate costs.
service and network management),
analysis, market shaping, and value
business process implementation, change Acted as key contact for office on
proposition development in the insurer
management, communications and healthcare startups and organized
and health system channel for first FDA-
training. informational presentations for consultants
approved Biosimilar.
by healthcare startups including behavioral
Senior Associate
Drove practice transformation and data health and diabetic management
2015 – 2018
initiatives in the largest urology group in companies.
America for innovative payment reform Redesigned a health system’s care
Coordinated medical insurance RFPs and
program aimed at improving oncology care. management model across their 10
summarized and illustrated results for
hospitals through orchestrating three
THE KINETIX GROUP, New York, NY executive management.
100+ person interactive design sessions
Director with frontline staff, doctors and leaders NORTH SHORE LIJ TRANSPLANT
2013 – 2018 with the goal of providing the right level CENTER, Manhasset NY
Led multiple market access and payor of patient care based on disease acuity Administrative Intern
marketing projects for pharmaceutical in the right care setting to reduce acute Summer 2013
clients. care length of stay, cost of care, and
increase patient experience. Collaborated on a three-person consulting
Preformed internal change management, team focused on strategic outreach
market positioning, research, branding, Identified over $120M in margin projects aimed at increasing patient
and annual planning activities for a $7B eye enhancement opportunities across an volume.
care company to establish a new strategic 11 hospital health system in their 15+
non-clinical shared services departments Wrote business plan and presentation for
account management organization.
and worked directly with leaders to establishment of an outpatient.
Researched, authored, and pitched new further analyze cost drivers and prioritize
business presentations to pharmaceutical initiatives to align costs with the system’s
companies and national health systems, strategic priorities.
presenting a patient-centric approach to
market access. Associate
2013 – 2015
Analyzed healthcare provider deals
(operational due diligence, clinical
synergies, volume trending), revenue
cycle (cash collections trending over
baseline), and academic medical centers
(funds flow).
21
2020 : Hamlin - Landsman
BRITTANY HAMLIN PRATEEK HANDA ALEXANDER HRYHOROWYCH

bhamlin20@gsb.columbia.edu phanda20@gsb.columbia.edu ahryhorowych20@gsb.columbia.edu
Finance and Technology Management and Consulting Consulting and Management
Mailman School of Public Health Shri Ram College of Commerce Columbia Business School
New York, NY New Delhi, India New York, NY
MPH, 2021 BA, Economics, 2013 MBA, 2020
Cornell University
Ithaca, NY FIDELITY GROWTH PARTNERS, ZS ASSOCIATES, New York, NY
BA, Biology and Society, 2015 Mumbai, India Associate Consultant
Investment Professional 2017 – 2018
PUTNAM ASSOCIATES, Boston, MA 2015 - 2018
Executed due diligence on business
Senior Associate Consultant
Led product and market diligence for key development opportunities for Fortune
2017 – 2018
plasma products, and created investment 100 biopharma client.
Executed valuation for successful thesis to conclude India’s first PE
Served in contract position as Global
partnership between pre-IPO transaction in the space.
Commercial Portfolio Director at a Fortune
biotech company and $3B Japanese
Tested efficacy of marketing plan of optical 100 pharmaceutical firm.
pharmaceutical manufacturer in the
retail chain by leading a consumer survey;
Japanese depression market. Revamped commercial strategy for a $1B
used findings to simplify and redesign
vaccine brand, resulting in 4% increase in
Led team of 5 to develop financial pricing structure.
one-year sales.
forecast for $1B+ anti-depressant across
Examined commercial viability of a
7 developed markets (US, EU5, Japan) Served as assistant launch manager for an
portfolio of twenty generic molecules
by integrating provider and payer key oncology drug gaining a new indication.
across several parameters to gain approval
opinion leader (KOL) feedback, company
for investment. Business Analyst
financials, and secondary market research.
2015 – 2017
AVENDUS CAPITAL, Mumbai, India
Associate Consultant
Investment Banking Analyst Drove turnaround of an underperforming
2016 – 2017
2014 - 2015 hemophilia brand by diagnosing cause of
Built dynamic financial model for leading patient loss and recommending remedy
Identified potential cross-border and
pharma company in immuno-oncology strategies.
domestic M&A targets for healthcare and
space evaluating strategic pricing and
IT clients. Designed patient-flow forecast model
contracting structures to hedge against
competitive entrants. distributed to 45 country brand leads.
Selected, as part of a 3-member team, to
set up healthcare practice; generated a ALPHASIGHTS, New York, NY
BRIGHAM AND WOMEN’S HOSPITAL, 20+ lead pipeline.
Boston, MA Lead Analyst, Analyst
Research Coordinator 2013 – 2015
2015 Managed relationships with ~50 clients
Managed engagement with 400 national from a management consulting firm, driving
sites and 7,000 patients on an NIH- over $400K in annual revenue.
funded clinical trial, while coordinating Performed opportunity assessment to
diverse teams in the successful delivery of prioritize growth practice areas in largest
cardiovascular trial products. client account.
Initiated audits and resolved $10,000 in
payment discrepancies across 400 sites;
Developed payment checklist to ensure
quality control which resulted in 100% on-
time delivery.

DANIELLE LABARBIERA JENKS LIZA KIND JAMIE LANDSMAN
djenks20@gsb.columbia.edu lkind20@gsb.columbia.edu jlandsman20@gsb.columbia.edu
Technology and Strategy Consulting and Strategy Consulting and Strategy
Cornell University University of Michigan Cornell University

Ithaca, NY Ann Arbor, Michigan Ithaca, NY
BS, Chemical and Biomolecular BA, Political Science, Complex Systems, 2014 BA, Policy Analysis and Management, 2014
Engineering, 2015
ENGLEWOOD HEALTH, Englewood, NJ THE ADVISORY BOARD COMPANY,
DELOITTE CONSULTING, New York, NY Chief of Staff Washington, DC
Strategy and Analytics Consultant 2015 – 2018 Senior Analyst
2017 – 2018 2018
Served as extension of CEO leading
Developed optimized provider data strategic initiatives, spearheading Advised hospital c-suite and finance
processes for $35B+ health plan, organizational improvements, and executives on topics including cost-control
achieving annual savings of $15M+ by increasing financial performance. strategies, federal payment policies,
reducing redundant technology and revenue cycle optimization.
Collaborated with senior leadership
increasing employee efficiency.
to create ten year strategic plan; led Led workstream on optimizing revenue
Pioneered value-based care payment behavioral health pillar of plan with focus capture best-practices; Designed revenue
strategy that enabled health plan to align on outpatient expansion. cycle maturity model to assess client
technology and operations across five capabilities.
Oversaw $6.5 million budget and over 100
states.
employees of Food & Nutrition Services Analyst
DELOITTE CONSULTING, New York, NY Department. 2016
Business Technology Analyst
FTI CONSULTING, New York, NY Authored five white papers and
2015 – 2017
Health Solutions Consultant contributed to four 90-minute
Developed 250+ business requirements 2014 – 2015 presentations on physician alignment,
by prioritizing and redesigning digital consumer-focused healthcare, and
Developed litigation support for large
user experience for boutique retailer. organizational transformation of operations
national retail pharmacy, including forensic
for 3,000+ hospital leaders.
Analyzed F500 provider’s data usage analysis of large transaction data sets.
and designed streamlined data storage
Identified opportunities for revenue
procedure, reducing storage costs by
optimization for ten national health
98%+ and cutting response time by 50%+.
systems.
23
2020 : Li - Mustafa
CHLOE LI, CPA ERIK MAI KUNAL MALHOTRA

zhli20@gsb.columbia.edu emai20@gsb.columbia.edu kmalhotra20@gsb.columbia.edu
Finance and General Management Finance and Entrepreneurship Consulting
Columbia Business School Columbia College Motilal Nehru National

New York, NY New York City, NY Institute of Technology,
MBA, Healthcare and General Management BS, Biochemistry and Business Management, Allahabad, India
2020 2013 B.Tech, Electronics and Communication
2012
Emory University MODERNA THERAPEUTICS,
Atlanta, GA Cambridge, MA ZS ASSOCIATES,
BBA, Finance and Accounting Senior Manager, Corporate Strategy New York, NY
2012 2017 – 2018 Project Lead, 2017 - 2018
Senior Analyst, 2016 - 2017
CASTLETON COMMODITIES INT’L, Created valuation materials for $500M
Stamford, CT Series-G private placement. Led team of cross-functional experts to
Associate Director, Tax Manager Collaborated with GMP manufacturing examine market scenarios and business
2015 – 2018 team to create roadmap to lower COGS. assumptions to enable decision around
$4B acquisition.
Managed team of four professionals to Implemented new process to assess
ensure accurate income tax filings and risk across the portfolio to influence Conducted commercial due diligence to
restructuring of 50+ legal entities with development candidate nomination. guide strategic investment decisions.
complex legal structures across multiple
Devised business plans for clinical Optimized size and design of sales force
jurisdictions including U.S., Canada,
programs considering commercial teams to accommodate new product
Singapore, China and Europe.
opportunity, unmet need, risk, launch.
Built robust analyses of $17BN annual sales development speed/cost, and synergies Managed relationships with multiple clients
data from SAP to establish company’s across the portfolio. and coordinated with offshore technical
first-ever state apportionment allocation
staff to deliver predictive analytic projects.
method, saving on tax assessments in 13 HEALTH ADVANCES, Boston, MA
states. Consultant, Case Team Leader New Delhi, India
2013 – 2016 Associate Consultant, 2014 – 2016
Implemented tracker process within Tax,
Treasury, Credit, Risk and Legal teams Strategy consultant advising clients across Associate, 2012 – 2014
to document company re-domiciliation the healthcare spectrum: biopharma,
and daily operations under FATCA and Developed patient journey insights and
medical devices, diagnostics, HIT, and
common reporting standard regimes; measured performance of sales channels
healthcare services.
reduced turnaround time by 10-14 days per by analyzing patient level data.
request Led diligence efforts to evaluate
Assessed multi-channel promotional
competitive landscapes and forecast peak
strategy by identifying and targeting
KPMG LLP, Stamford, CT sales across different scenarios.
physician segments based on promotion
Senior Associate, Tax Constructed a ‘go-to-market’ blueprint receptivity.
2014 – 2015 for a novel therapeutic capturing sales
Created statistical tool to predict post LoE
Led teams of 10+ tax professionals in tax and marketing requirements and HEOR
market share erosion.
compliance and planning engagements materials.
with annual budget totaling $10MM for Analyzed speciality pharmacy sales
Evaluated life-cycle management strategies
clients across banking, mutual funds, real and interactions data to measure store
for blockbuster brand.
estate, energy, retail and Technology, performance.
Media & Telecommunications sectors Chair of the Business Analytics and
Forecasting Committee.
DELOITTE TAX LLP, Atlanta, GA
Tax Consultant
2012 – 2014

EMMA McGREGOR ANISHA MUKHERJEE ZAID MUSTAFA
emcgregor20@gsb.columbia.edu amukherjee20@gsb.columbia.edu zmustafa20@gsb.columbia.edu
Consulting, Strategy and Technology Strategy and Corporate Development Consulting
University of Michigan Duke University McGill University

Ann Arbor, Michigan Durham, North Carolina Montreal, Canada
BSE, Industrial and Operations Engineering, BSE, Biomedical Engineering, 2014 BA & BSc., Molecular Biology and
2015 Economics, 2015
WG GROUP, New York, NY
EMTEC, INC., Chicago, IL Senior Analyst DHL CONSULTING, Miami, FL
Senior Consultant 2018 Senior Management Consultant
2018 2018
Organized and conducted advisory
Designed and built an integrated platform boards to solicit feedback from key Led various international engagements
to consolidate a financial services stakeholders on delivery model of to advise Life Sciences and Healthcare,
client’s nine disconnected systems used Schedule III drug and developed key Technology and Logistics clients.
for housing financial information and recommendations for implementation.
performing daily activities. Headed business development for Life
Leveraged findings from systematic Sciences sector as youngest-ever board
Conducted client team interviews literature review to determine clinical member, directly acquiring 10 new
to gather and document over 200 endpoints to guide clinical trials for projects (>50% success rate).
requirements across three business areas regenerative medicine asset.
and identified specific operational and MEAKINS CHRISTIE LABORATORIES,
workflow solutions. OUTCOME HEALTH, New York, NY Montreal, Canada
Associate, Sales Strategy and Operations Research Intern
Presented project plans, process 2017 2014
improvements, and industry best practices
to C-level client stakeholders. Collaborated with COO to develop new Designed and carried out
organizational structure that leveraged experimentation on the effects of IL-
Owned the training and knowledge pharma industry insights. 17a on cytokine production in severe
transfer of a client’s financial processing persistent asthma, resulting in paper
and data maintenance to a new hire. Partnered with SVPs to track pipeline publication.
of ~$25M, pacing to quota and provide
NATIONWIDE CHILDRENS HOSPITAL strategies to maximize size of deals
Columbus, OH ranging from $100K - $1M.
Business Process Improvement Intern
2013 – 2014 CBPARTNERS, New York, NY
Senior Analyst
Mentored hospital managers through 2015 – 2017
internal operational excellence training
focused on teaching Lean and Six Sigma Conceived, architected, and piloted
principles through department-specific global rotation program for employees
projects. to gain international exposure and build
more cohesive culture across offices;
Led a project to predict Admissions resulted in 3 applicants in first year;
volume and presented hourly staffing completed 7-month rotation in London,
recommendations to accommodate the UK.
expected number of patients over the
16-hour day. Built dynamic pricing tool to predict
prices of future drugs agnostic of clinical
Conducted time studies and analyzed data in EU5 used by client for forecasting.
results to recommend the number of time
clocks needed to meet demand.
25
2020 : Nimmo - Reis
JOHN NIMMO MARGARET O’BRIEN MATTHEW PESESKY

jnimmo20@gsb.columbia.edu mobrien20@gsb.columbia.edu mpesesky20@gsb.columbia.edu
Private Equity and Management Social Enterprise and Finance Investment, Management and Technology
Dartmouth College Bucknell University University of Virginia

Hanover, NH Lewisburg, PA Charlottesville, VA
BA, History, 2013 BA, Economics and Spanish, 2014 BA, Distinguished Majors
Program in History, 2012
GEMINI INVESTORS, Wellesley, MA HEALTH ADVANCES, Weston MA
Private Equity Associate Engagement Manager, Consultant ONECITY Health
2015 – 2018 2017 – 2018 Data Science Intern
October 2018 – present
Executed six new platform investments Developed growth-focused strategic
across a range of industries including home recommendations for 50+ clients Structuring and analyzing referral and
health and dermatology. across healthcare industry, including service data through the NowPow program
biotech, pharmaceutical, medical device, to empirically maximize care effectiveness.
Built financial models, conducted business
diagnostics, and Health IT companies,
due diligence, authored and presented Reporting to the Chief Analytics Officer.
PE/VC funds, and healthcare trusts/
investment committee memorandums and
foundations. OPTUM, Washington, DC
managed third party transaction advisors.
Managed case teams of 3-8 consultants, Senior Research Consultant
Monitored ten portfolio companies, 2017 – 2018
overseeing work-streams, synthesizing
supporting management teams’ strategic
findings, and presenting to clients. Directed product creation for the firm’s
planning efforts, additional financing
needs, and acquisition screening and Devised US and EU market access medical technology unit (150 clients) to
execution. and pricing strategies for a platform provide increased data transparency and
biotechnology company with several Phase identify opportunities for strategic growth.
Evaluated over 300 investment
II and III assets. Spearheaded development and release
opportunities annually.
of data-focused product enhancements,
Senior Analyst, Analyst
PARTHENON-EY, Boston, MA leading to 99% medical device client
2014 – 2017
Senior Associate, 2015 retention.
Associate, 2013 – 2015 Prioritized >100 grantees for a large
healthcare trust to partner with to THE ADVISORY BOARD COMPANY,
Provided M&A advisory, market due Washington, DC
advance the trust’s core mission of curing
diligence and growth strategy services to Consultant
Type 1 diabetes.
private equity and corporate clients within 2012 – 2017
the healthcare practice. Assessed the revenue trajectory of
several antibiotic classes as part of a due Served as acting practice manager for
Conducted primary and secondary $16M Health Care Industry unit from
diligence.
research, executed customer segmentation February-July 2017. Led five-member
analysis, and prepared presentations to Prioritized organic and inorganic growth research staff and partnered intensively
advise clients on key strategic questions. opportunities for capital deployment on with 18-member commercial team.
behalf of an aspiring CNS biotech.
Co-Chair of Summer Associate Program Completed custom projects for 23 of the
and Dartmouth Undergraduate Recruiting Built revenue forecasts, capturing 25 largest global medical device firms.
Captain. competitors, reimbursement, physician
reception, and payer feedback to feed into
NPV models.
UNITED STATES SENATE, Washington D.C.

Legislative Intern, 2012
Assisted healthcare legislative
correspondent by attending congressional
meetings, researching policy areas, and
crafting briefings/legislation.

ANDREA RADKE MODAK RAJ STEPHEN REIS, MD
aradke20@gsb.columbia.edu mraj20@gsb.columbia.edu sreis20@gsb.columbia.edu
Consulting and Marketing Management and Consulting Consulting and Private Equity
Brown University St. John’s University, College of Pharmacy New York Medical College, Valhalla, NY
Providence, Rhode Island and Health Sciences School MD, 2007
AB, Biology & Pre-Medicine, 2013 New York, NY
MS, Industrial Pharmacy, 2012 University of California, San Diego
UNITEDHEALTHCARE, Minnetonka, MN San Diego, CA
Program Manager of Advanced Reporting & Manipal University, College of BS, Biochemistry and Cellular Biology, 2003
Analytics for Provider Services Pharmaceutical Sciences,
2017 – 2018 Manipal, India COLUMBIA UNIVERSITY IRVING MEDICAL
BS, Pharmaceutical Sciences, 2009 CENTER, New York, NY
Spearheaded executive reporting and data Assistant Professor of Radiology, Director of
readiness for health plan expansion adding CONTINEO HEALTH, New York, NY Interventional Radiology Research
45,000 providers to UHC’s central region. Practice Lead, Population Health 2016 – Present
Facilitated application upgrade by 2012 – present
Advised and Implemented switchover to
ensuring cross-functional collaboration and Led and advised institutional healthcare Epic Electronic Medical Records as part of
implementation between business and IT client on implementing electronic health the Clinical Leadership Group.
to maintain data security and reporting record systems.
reliability for 650,000 providers. Directed Interventional Radiology Services
Led and advised healthcare organization at NYP Lawrence hospital and oversaw
UNITEDHEALTHCARE, Minnetonka, MN and accountable care organizations to 20% year over year growth.
Manager of Customer Care Reporting meet the healthcare regulatory reporting
2016 – 2017 tied to payor based financial incentives. UT SOUTHWESTERN MEDICAL CENTER,
Dallas, TX
Managed 12-person global reporting team Evaluated investment opportunities Assistant Professor of Radiology,
constructing visual reports from UHC for seed stage funding in high impact Interventional Radiology Quality
national call center data. healthcare segment. Improvement Liaison
Hired top-talent to bolster operational 2013 – 2016
performance. Tripled productivity Designed and managed the interventional
in database optimization project. radiology quality improvement program.
Transformed data run time to expedite
data delivery to customers. Lead the interventional radiology division
in research production during 3-year
Led first UHC provider experience tenure.
reporting initiative on quality metrics such
as issue turnaround time and inventory
control.
OPTUM, Eden Prairie, MN

Healthcare Payer Consultant
2013 – 2016
Leadership Acceleration Program
Graduate: Achieved high customer
satisfaction on a variety of healthcare
consulting engagements while completing
over 60 trainings in under three years.
27
2020 : Rivera - Rusinkiewicz
ARMANDO RIVERA JOANNA ROBERTS ERNIE RODRIGUEZ-DUMONT

arivera20@gsb.columbia.edu jroberts20@gsb.columbia.edu erodriguezdumont20@gsb.columbia.edu
Strategy and Finance Pharmaceutical and Biotechnology Finance
University of Rochester University of Pennsylvania Columbia University College

Rochester, NY Philadelphia, PA of Physicians and Surgeons
BA, Financial Economics, 2012 BA, Philosophy, Politics, and Economics, 2015 New York, NY
MD, 2008
SURESCRIPTS LLC, Arlington, VA DELOITTE & TOUCHE, New York, NY
Senior Corporate Strategy Analyst, Consultant University of Puerto Rico, Rio Piedras
2017 – 2018 2017 – 2018 San Juan, PR
Corporate Strategy Analyst, BS, Chemistry, 2004
Provided regulatory and compliance
2015 – 2017
services to pharmaceutical, biotechnology, NYU LANGONE HOSPITAL, Brooklyn, NY
Collaborated on all corporate strategy laboratory, and medical device clients. Attending Physician
activities reporting into the office of the 2013 - 2018
Implemented a risk assessment and
CEO.
mitigation planning process for an opioid Supervised and managed operation
Tracked companies and monitored trends addiction manufacturer, including systems of nurses and residents teams in the
in the pharmacy, PBM and health IT and transactions reviews and field force diagnosis, triage, treatment, and delivery of
subsectors; crafted market briefings and monitoring. obstetrical patients in a Labor and Delivery
reports to update the organization and Unit.
provide context around material events. HURON CONSULTING GROUP
New York, NY Performed minimally-invasive gynecologic
Validated and secured approval for new Analyst surgeries, including life-saving and
transaction pricing strategy through 2015 – 2017 emergent procedures.
scenario modeling of adoption, utilization
and revenue generation for multi-sided Improved and maintained compliance with Awarded with The American College of
network product; resulted in >40% monthly industry guidelines and federal regulations Obstetricians and Gynecologists CREOG
transaction volume increase in 9 months. for pharmaceutical, biotechnology, National Faculty Award and twice with the
laboratory, and medical device clients. Association of Professors of Gynecology
Acted as an internal consultant and and Obstetrics Excellence in Teaching
analytical lead on diverse set of projects, Developed policies, procedures, and
Award.
including: channel partner strategy, frameworks to support healthcare
customer incentive analysis, product professional management including MEMORIAL SLOAN KETTERING
strategy, business model transformation contracting, fair market value CANCER CENTER, New York, NY
and white paper authoring. determination, and auditing and monitoring Research Fellow
in domestic and EMEA markets.
IMS HEALTH, New York, NY Analyzed medical records and identified
2013 – 2015 relevant information to feed into a
department-wide database used for
Created client dashboards for analysis of research in innovative surgical techniques
pharmaceutical sales and associated price for advanced gynecological cancers.
concessions across distribution channels
using Tableau data visualization software. ICAHN SCHOOL OF MEDICINE AT
MOUNT SINAI HOSPITAL, New York, NY
Linked and standardized customer data
Ob/Gyn Resident Physician
sets from current and legacy revenue
2008 - 2012
management systems using Microsoft SQL
Server. Synthesized current labor management
research and presented findings in
departmental Grand Rounds.

ARIEL ROKITO TANYA ROSENBLUT STEPHANIE RUSINKIEWICZ
arokito20@gsb.columbia.edu trosenblut20@gsb.columbia.edu srusinkiewicz20@gsb.columbia.edu
Entrepreneurship and Private Equity Management and Social Enterprise Management and Marketing
Cornell University Columbia Business School Stevens Institute of Technology

Ithaca, NY Columbia University Mailman Hoboken, NJ
BS, Policy, Analysis & Management, 2015 School of Public Health ME, System Engineering, 2011
New York, NY BE, Biomedical Engineering, 2011
ANALYSIS GROUP, New York, NY MBA/MPH, 2020
Senior Analyst INTEGRA LIFESCIENCES, Tullamore, Ireland
2016 – 2018 BRUNSWICK GROUP, New York, NY Quality Manager
Account Director 2017 – 2018
Defined market size for various disease
2015 – 2018
areas to estimate the financial impact Department head overseeing 17.
to insurance payers of the launch of Led market research and data analytics
Instituted personal accountability culture
new medical interventions; constructed projects on corporate reputation, multi-
that increased production plan attainment
models that predicted annual cost stakeholder messaging, and corporate
by 25% and 50% improvement in Quality
savings ranging between ~$2M and $5M. crisis management for Fortune 500
scorecard.
companies.
Developed econometric model to
quantify costs and benefits of a novel Developed a multi-stakeholder reputation INTEGRA LIFESCIENCES, San Diego, CA
gene therapy in pediatric oncology; tracker for a large US insurance provider, Site Quality Lead
model was submitted to 8 government the results of which were delivered to the 2016 – 2017
drug approval agencies across Europe CEO’s team to inform strategic decisions Transformed manufacturing site from low
and Asia and drug received EU approval for the company. performer to a division leader which lead
in August 2018. to a premium sale price in force divesture.
Conducted an in-depth provider
Managed team of three analysts and led communications audit for a Fortune 500 Restructured & drove site goals to achieve
meetings with pharmaceutical client to healthcare company and developed an a 30% increase is capacity.
present economic model for pipeline optimized document approval process that
hemophilia treatment; built model which prevents employee burnout and reduces INTEGRA LIFESCIENCES, Plainsboro, NJ
created transparency of competitive expenses. Senior Quality Engineer & Quality
treatment landscape and was used by Compliance Specialist
clients in pricing decisions. THE DATING RING, New York, NY 2013 – 2016
Matchmaker
Analyst 2015 – 2016 Trained 12 sites globally on inspections
2015 – 2016 management and managed 8 successful
Leveraged proprietary software and FDA inspections.
Quantified damages from off-label interpersonal relationships expertise to
promotion of pharmaceutical drugs identify optimal matches for members. INTEGRA LIFESCIENCES, Andover, UK &
in $280M commercial disputes case; Plainsboro, NJ
created exhibits from medical claims ECONOMISTS INCORPORATED, Rotational Leadership Development Program
data used in the expert testimony of Washington, DC 2011 – 2013
a research associate at the National Research Associate
Bureau of Economic Research. 2012 – 2014 Received 510k regulatory approval.
Conducted statistical analysis of survey Performed statistical and economic Facilitated International Clinical Trial.
data for 960 patients with diabetes analysis using Stata and SPSS for economic Implemented new customer complaint
(across 7 countries) to quantify factors litigation casework, primarily in the process, resulting in 70% decrease in cycle
that drive insulin adherence; results were provider space. time.
presented at the 77th Scientific Sessions Evaluated complex datasets to create
of American Diabetes Association. tangible deliverables presented as expert
testimony to the DOJ and FTC.
29
2020 : Satish - Thomson
SHRUTI SATISH DANIEL SCHWEBER VICTORIA SERRANO

ssatish20@gsb.columbia.edu dschweber20@gsb.columbia.edu vserrano20@gsb.columbia.edu
Marketing and Technology Entrepreneurship and Strategy Management, Operations
and Clinical Research
Yale University University of Michigan
New Haven, Connecticut Ann Arbor, Michigan CUNY School of Public Health
BA, Economics, 2014 BA, 2010 at Hunter College,
New York, NY
DELOITTE CONSULTING, Washington, DC ZOCDOC, New York, NY MPH, 2005
Senior Consultant Dedicated Advisor
2018 2017 – 2018 COLUMBIA UNIVERSITY MEDICAL
CENTER, New York, NY
Advised strategy and implementation of Enterprise sales & account management
Administrative Director &
Navy program initiatives improving access professional focused on hospital client
Director of Clinical Research
and care coordination for 83,000+ chronic accounts.
2002 – Present
pain patients across 7 military hospitals.
Directly oversee multiple metro markets
Handle all aspects of operations for the
Designed, piloted, and led three-fold representing $3.5M in annual contracts,
Center’s outpatient clinic, clinical research
expansion of opioid safety initiative; growing current and new accounts within
and basic science laboratory sectors.
developed messaging, recruited clinician territory.
liaisons and coordinated analytics-driven Oversee all HR, administrative and
Manage a team of 3 focused technical
patient monitoring efforts, reducing financial matters for the 26 staff & faculty
implementations, account service, and
number of patients on long-term opioid that comprise the Center.
sales.
therapy by 15%.
NEW YORK UNIVERSITY LANGONE
EVERDAY HEALTH, New York, NY
Consultant MEDICAL CENTER, New York, NY
Director, Community Development
2016 – 2018 Program Coordinator
2016 – 2017
2009 – 2011
Built consensus across multidisciplinary
Led business development, account
clinician team to develop first military Focused on all protocol development,
management, operations, and customer
policy documenting physician protocols for regulatory and financial aspects for 20+
support for software business focused on
managing long-term opioid patients. clinical trials, while supervising 4 clinical
hospitals and medical schools (acquired
research coordinators.
Identified Military Health System use case for MD).
for patient-reported outcomes collection Created and negotiated budgets for
Keynote speaker at medical education
technology; placed 3rd in account-wide BD all hematology oncology clinical trials
industry events.
contest after pitching solution offering to increasing the per-patient costs by
firm leadership. FORMD, New York, NY approximately 25% in most budgets.
Director, Community Development
Analyst COLUMBIA UNIVERSITY MEDICAL
2013 – 2015
2014 – 2016 CENTER, New York, NY
Grew business from 0 to 100 hospital Senior Research Manager
Engaged end users to understand and
accounts. 2008 – 2009
communicate requirements to design
team, increasing functionality and user HURON CONSULTING GROUP, Chicago, IL Supervised the conduct of 7 clinical trials
adoption during FDA implementation Healthcare Consultant and database projects and 3 research staff
of workflow management platform to 2011 – 2013 within the Pancreas Center.
expedite review of generic drugs.
Directed enterprise software Supervised and assisted with the forensic
Synthesized leading practices from market implementations for 100s of users at work and implemented extensive
research to advise Navy Chief Medical various health systems. corrective action plans, SOPs and SPIs to
Officer on creation, socialization and obtain approval from the IRB and OHRP
implementation of new organizational Integrated billing and collections function for a clinician to re-open his clinical trials
operating model to better enable provider- for 153 hospital system into consolidated after suspension.
led care delivery innovation, earning top center.
leadership approval.

EMILY STOOPLER AARTI TARKAR IGNACIO THOMSON
estoopler20@gsb.columbia.edu atarkar20@ gsb.columbia.edu ithomson20@gsb.columbia.edu
Strategy and Operations Management and Consulting Investment Banking
Columbia University School of Social Work University of Connecticut, Storrs, CT Ph.D. in Instituto Tecnológico de Buenos Aires (ITBA)
New York, NY Physiology and Neurobiology, 2015 Buenos Aires, Argentina
M.S.S.W., 2012 MS in Cell Biology, 2009 BSc, Industrial Engineering
Cornell University GLAXOSMITHKLINE, COLLEGEVILLE, PA, GRUPO FINANCIERO GALICIA,

Ithaca, NY Investigator and Biology Manager, Buenos Aires, Argentina
B.S., 2010 Discovery Partnerships with Academia Strategy Associate
June 2017 – Present 2016 – 2018
NEW YORK-PRESBYTERIAN HOSPITAL,
New York, NY Structured research ideas and Spearheaded first-ever bank spin-off in
Psychiatric Social Worker experimental plans to gain insights into Argentina and first follow-on offering of
2012 – 2018 pathophysiology of anemia, oncology and GGAL ($633M) priced at all-time high
immunology. price.
Counseled adult hospital inpatients with
acute psychiatric diagnoses. Identified novel treatment mechanism that Headed post-merger integration of a
would help patients with iron overload 20-branch bank. Synchronized activities
Coordinated safe and timely discharge disorders. of IT, operations, marketing, retail
plans for patients to reduce hospital banking, HR, audit, accounting and legal
length of stay. Directed key experiments for evaluating
departments.
novel genes implicated in pancreatic
Presented cases in interdisciplinary cancer and lymphomas to be therapeutic ITAU BBA, Buenos Aires, Argentina
rounds with doctors and nurses. targets. Investment Banking Analyst
Interfaced with insurance companies to Managed internal GSK and external 2012 – 2016
obtain prior authorizations for inpatient universities’ stakeholders to ensure Closed 15+ M&A, ECM and DCM deals
hospital admissions. effective execution of program research across Argentina, Brazil, Chile, Peru,
objectives. Colombia and Ecuador, totaling $10+ bn.
PUTNAM FAMILY AND COMMUNITY
SERVICES, Carmel, NY Organized the 4th annual conference Key liaison with client’s management,
Social Work Intern for Women’s Leadership Initiative that leading daily interaction with cross-border
2010 – 2011 provides members with opportunities to and cross-functional teams.
develop leadership and other skills. Performed exhaustive valuation and
Engaged clients with severe and
persistent mental illness in treatment by modeling analysis, including multiples,
Postdoctoral Scientist, Ischemic
conducting home visits. DDM, residual income, LBO, merger
Myocardial Injury, Heart Failure DPU
consequences , sum-of-the-parts and
Developed long-term, client-centered 2015 – 2017
accretion-dilution analysis.
treatment plans. Led first-in-class initiative of big data
Tailored different valuation methods to
analysis to develop profile for pathways
JEWISH BOARD OF FAMILY AND account for macro-distortions in LatAm
altered following heart failure.
CHILDREN’S SERVICES, New York, NY capital and money markets.
Social Work Intern Identified mechanism of action for
Summer 2011 candidate drug molecules for treatment
of myocardial infarction that is an unmet
Interviewed and evaluated medical need.
undergraduate students seeking
internships with JBFCS.
Coordinated student placements with
JBFCS agencies.
31
2020 : Woodruff - Zhao
AMY WOODRUFF MINGMING WU LU YE

awoodruff20@gsb.columbia.edu miwu20@gsb.columbia.edu lye20@gsb.columbia.edu
Finance Marketing and Strategy Consulting, Investment
Research and Finance
University of Michigan University of Waterloo
Ann Arbor, MI Waterloo, Canada Fordham University
BS, Neuroscience, 2015 BMath, Actuarial Science and Financial New York, NY
Analysis, 2013 M.S. in Quantitative Finance, 2012
REGENERON PHARMACEUTICALS,
Tarrytown, NY MEMORIAL SLOAN KETTERING CANCER Southwest University of Science
Research Associate CENTER, New York, NY and Technology, Sichuan, China
2014 - 2018 Senior Investment Analyst Bachelor in Economics, 2010
2017 – 2018
Engineered and optimized cellular studies DBRS, Inc., New York, NY
to test drug candidates for the Immuno- Spearheaded research in US real Assistant Vice President, Structured Finance,
Oncology pipeline based on biological estate market by presenting analysis 2018
relevance and competitive landscape to of investment returns relative to other
determine lead drug selection for clinical industries; resulted in team’s decision to Senior Financial Analyst,
trials. invest $20M in a real estate fund. 2016 – 2017
Worked collaboratively across Oncology Led a cross-functional team to migrate Financial Analyst,
department and led in-vitro based assay investment reporting processes to new 2013 – 2015
team on diverse portfolio of 50 Immuno- system; upgraded to enhanced reports.
Oncology drug targets, which resulted in Formulated credit ratings on deal team
advancing over 7 drugs to clinical trials and Investment Analyst of eight analysts for 60+ complex RMBS
one FDA approval for PD-1 drug molecule, 2016 – 2017 transactions; rating recommendations
Libtayo. resulted in #1 market share of DBRS in the
Rebuilt two existing tools into automated
largest segment in private RMBS market by
Analyzed and presented lab results templates that aggregate fund returns to
end of 2017.
to senior management; made quantify portfolio risk, using self-taught
recommendations about which drugs to VBA programming skills; improved time Created prototype of analytical tool
advance. spent from 2 hours to less than 10 minutes to assess risks underlying prepayment
volatilities unseen in previously rated
MERRILL LYNCH PRIVATE BANKING AND CANADA PENSION PLAN INVESTMENT deals, facilitating an expedited closing of a
INVESTMENT GROUP, Boston, MA BOARD, Toronto, Canada $240MM deal issued by a top 15 fixed-
Intern ($360B assets under management) income hedge fund.
2013 Investment Analyst
2013 – 2015 Supervised a team of three to manage
Led new company initiative to expand seamless execution of eight RMBS deals
investment portfolio to include socially Owned domain knowledge in the US across three parties by coordinating all
responsible investments. health insurance, healthcare IT, and communications with issuer, underwriting
hospitals industries. manager, and diligence vendor and training
Identified socially responsible companies
Built database of national Medicare clients on rating methodology.
and initiated meetings to research
competitor product offerings of an coverage and presented insights that Initiated six-month cross-training of two
emerging market niche to inform Merrill showed sustainable competitive advantage Canadian analysts, facilitating assistance of
Lynch’s launch of a new product offering in of a health insurance company, culminating Canadian counterparts in US transactions
ESG investments. in an investment in the company that and cultivating interdepartmental
returned 50% over 6 months. relationship.
Spearheaded an annual research project
on deal performance, housing market
trends and RMBS market outlook.

CARLOS ZARAZUA JOSHUA ZENILMAN TIFFANY ZHAO
czarazua20@gsb.columbia.edu jzenilman20@gsb.columbia.edu yzhao20@gsb.columbia.edu
Strategy and Consulting Strategy, Growth and Scaling Pharmaceuticals and Consulting
University of Notre Dame Washington University in St. Louis Columbia University
Notre Dame, Indiana St. Louis, MO Fu Foundation of Engineering
BBA, Finance and Economics, 2012 BS, Finance and International Business, 2013 MS, Biomedical Engineering, 2014
VMG HEALTH, Dallas, TX
CAIN BROTHERS & COMPANY, University of California, San Diego
Manager – Business Valuation
San Francisco, CA La Jolla, CA
2017 – 2018
Associate BS, Bioengineering, 2013
Delivered minority and control level 2016 – 2018
business valuations and transaction MSQ VENTURES, New York, NY
Advised on 15+ transactions totaling in VP, Healthcare (Pre-MBA Internship)
advisory services in the health care
excess of $2.5B+ of aggregate transaction 2018
services space.
volume.
Mentored and developed a team of 4 Provided strategic advice to early- to
Led junior banker coverage of multiple late-stage pharma companies looking for
analysts and a senior analyst through
subsectors (outsourced hospital services, international partners / investors.
proactive goal-setting and consistent
multi-site/retail health care, post-acute
feedback.
care); drafted industry perspectives, and THE DEDHAM GROUP, New York, NY
Managed and executed entire life-cycle tracked prospective client targets. Senior Analyst
of 8-12 valuations per month from the 2016 – 2017
initial evaluation, scope, budgeting, and CAIN BROTHERS & COMPANY,
San Francisco, CA Performed competitive landscape
resource management stage through the
Analyst assessment and optimized patient access
end of the engagement.
2013 – 2015 by enhancing patient-assistant program.
Senior Analyst – Business Valuation
Acted as sole analyst on a range of buyside Reinvented self-dispensing model for
2015 – 2017
and sellside M&A transactions oral oncolytics portfolio and constructed
Led client relationships with over 15 hospital system partnership strategies
clients annually, directing 5-10 projects Received early promotion to Associate to improve access and optimize value
per month and training and supervising 8 (three-year program; notified of promotion proposition.
individual analysts to deliver fair market after 2nd year, effective after 2.5 years).
value analyses and recommendations. REGENERON PHARMACEUTICALS,
Tarrytown, NY
Analyst – Business Valuation Research Associate II
2013 – 2014 2014 – 2016
Actively supported team by performing Designed and executed stability studies
detailed financial analysis and modeling, and implemented analytical methods to
due diligence, and report writing for 5-10 support formulation development from
valuations per month. initial screening through commercialization.
Advised on 5-10 small and large
transactions annually regarding
commercial insurance reimbursement
by performing black-box comparison
analyses of contracted reimbursement
rates for each party and expected post-
transaction reimbursement.
Co-authored an article published in
ImagingBiz demonstrating best practices
in the valuation of imaging centers
in response to increases in imaging
reimbursement.
33
NOTES
35
Healthcare & Pharmaceutical Management Program
www8.gsb.columbia.edu/healthcare
Healthcare Industry Association (HCIA)

columbiahcia.com

HCIA Resume Book 2019-2020

Uploaded by

Copyright:

Available Formats

HCIA Resume Book 2019-2020

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

HCIA Resume Book 2019-2020

Uploaded by

Copyright:

Available Formats

HEALTHCARE INDUSTRY ASSOCIATION (HCIA)

CLASS OF 2019 & 2020

8 ADITYA VIKRAM DAGA

10 GOKCE (GILLY) YILDIRIM 19 ZACK CAPLAN 27 ANDREA RADKE

11 ANGELIKA KOROMVOKI 20 ALEX EFRON 28 ARMANDO RIVERA

12 SAMANTHA MARTIN 21 TESS FINKEL 29 ARIEL ROKITO

13 ALEXA PICCIOTTO 22 BRITTANY HAMLIN 30 SHRUTI SATISH

14 HANNAH REITAN 23 DANIELLE LABARBIERA JENKS 31 EMILY STOOPLER

15 RON TAITZ 24 CHLOE LI 32 AMY WOODRUFF

16 SHIRLEY WANG 25 EMMA MCGREGOR 33 CARLOS ZARAZUA

2 2019-2020 HCIA RÉSUMÉ BOOK

4 2019-2020 HCIA RÉSUMÉ BOOK

LUCIE BARDET JOSHUA BARRETT IRINA BENIMOVICH

MARKENRY BENOIT JIEXIN CAI ALY CALLAHAN

The Pennsylvania State University Fudan University Lehigh University

BRISTOL-MYERS SQUIBB, Princeton, NJ MORNINGSIDE VENTURES, TRUVERIS, New York, NY

Brown University Wellesley College University of Michigan

ADITYA VIKRAM DAGA DANIYAL HUSSAIN CHRIS DENNEN

8 2019-2020 HCIA RÉSUMÉ BOOK

Created comprehensive commercial Developed 3-year U.S. prelaunch plan for

GOKCE (GILLY) YILDIRIM SHARIFF GONNELLA PARISA HEMATI

Columbia University Embry-Riddle Aeronautical University Sarah Lawrence College

10 2019-2020 HCIA RÉSUMÉ BOOK

King’s College London Georgetown University Columbia Business School

Provided project management support

SAMANTHA MARTIN AMANDA NICKLIN GUS NORTHROP

12 2019-2020 HCIA RÉSUMÉ BOOK

HANNAH REITAN AUSTIN SHAW CANDICE SU

14 2019-2020 HCIA RÉSUMÉ BOOK

Yale University University of Texas at Austin Wesleyan University

SHIRLEY WANG SHERIE ZHOU

Columbia Mailman School of Public Health University of Virginia

Princeton University STRATEGY&, New York, NY

WELLTHIE, INC., New York, NY Assessed physician and hospital landscape

16 2019-2020 HCIA RÉSUMÉ BOOK

BEN ASCHERMAN LESLYE BARTH ALEXANDRA CAMESAS

18 2019-2020 HCIA RÉSUMÉ BOOK

ALEX EFRON ISAIAH EINZIG MICHELLE FERBER

Pomona College Cornell University Northwestern University

20 2019-2020 HCIA RÉSUMÉ BOOK

Columbia University Cornell University University of Pennsylvania

BRITTANY HAMLIN PRATEEK HANDA ALEXANDER HRYHOROWYCH

22 2019-2020 HCIA RÉSUMÉ BOOK

Cornell University University of Michigan Cornell University

CHLOE LI, CPA ERIK MAI KUNAL MALHOTRA

Columbia Business School Columbia College Motilal Nehru National

24 2019-2020 HCIA RÉSUMÉ BOOK

University of Michigan Duke University McGill University

JOHN NIMMO MARGARET O’BRIEN MATTHEW PESESKY

Dartmouth College Bucknell University University of Virginia

UNITED STATES SENATE, Washington D.C.

26 2019-2020 HCIA RÉSUMÉ BOOK

OPTUM, Eden Prairie, MN

ARMANDO RIVERA JOANNA ROBERTS ERNIE RODRIGUEZ-DUMONT

University of Rochester University of Pennsylvania Columbia University College

28 2019-2020 HCIA RÉSUMÉ BOOK

Cornell University Columbia Business School Stevens Institute of Technology

SHRUTI SATISH DANIEL SCHWEBER VICTORIA SERRANO

30 2019-2020 HCIA RÉSUMÉ BOOK

Cornell University GLAXOSMITHKLINE, COLLEGEVILLE, PA, GRUPO FINANCIERO GALICIA,